Retatrutide 15mg

Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Available in a 15mg lyophilized vial, it is one of the most studied peptides in the field of metabolic and weight management research. Preliminary studies suggest significant potential in lipid metabolism, glucose regulation, and body composition research contexts.